ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1865 • ACR Convergence 2020

    Identification of Parameters Associated with a Diagnostic Delay in Axial Spondyloarthritis:Results from the European Map of Axial Spondyloarthritis (EMAS)

    Marco Garrido-Cumbrera1, Victoria Navarro-Compán2, Christine Bundy3, Raj Mahapatra4, Souzi Makri5, José Correa-Fernández6, Laura Christen7, Carlos-Jesus Delgado-Domínguez8 and Denis Poddubnyy9, 1Health & Territory Research (HTR), Universidad de Sevilla / Spanish Federation of Spondyloarthritis Associations, Sevilla, Spain, 2Hospital Universitario La Paz IdiPaz, Madrid, Pais Vasco, Spain, 3Cardiff University, Cardiff, United Kingdom, 4Axial Spondyloarthritis International Federation, London, United Kingdom, 5Cyprus League Against Rheumatism, Nicosia, Cyprus, 6Health & Territory Research (HTR), Universidad de Sevilla, Sevilla, Spain, 7Novartis Pharma AG, Basel, Switzerland, 8Health & Territory Research, Seville, Spain, 9Charité – Universitätsmedizin Berlin, Berlin, Germany

    Background/Purpose: Early diagnosis of Axial Spondyloarthritis (axSpA) is crucial for timely access to specialist care and effective treatment. The aim is to assess the current…
  • Abstract Number: 1866 • ACR Convergence 2020

    Patient-reported Impact of Axial Spondyloarthritis on Working Life. Results from the Spanish Atlas 2017

    Marco Garrido-Cumbrera1, Eduardo Collantes-Estévez2, Victoria Navarro-Compán3, Pedro Zarco4, Carlos Sastre5, Sergio Sanz-Gomez6, José Correa-Fernández7 and Jordi Gratacós8, 1Health & Territory Research (HTR), Universidad de Sevilla / Spanish Federation of Spondyloarthritis Associations, Sevilla, Spain, 2Rheumatology Department, Reina Sofia University Hospital/ Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ University of Cordoba, Cordoba, Spain, Córdoba, Spain, 3Hospital Universitario La Paz IdiPaz, Madrid, Pais Vasco, Spain, 4Novartis Farmacéutica Spain, Alcorcon, Madrid, Spain, 5Novartis Pharma AG, Basel, Switzerland, 6Health & Territory Research, Seville, Spain, 7Health & Territory Research (HTR), Universidad de Sevilla, Sevilla, Spain, 8University Hospital Parc Tauli Sabadell, Barcelona, Spain

    Background/Purpose: Axial spondyloarthritis (axSpA) impacts negatively on multiple dimensions of patient’s life, including their working life. The present study aims to evaluate working status, work-related…
  • Abstract Number: 1867 • ACR Convergence 2020

    Two-Year Diagnostic Consistency in Patients with Chronic Back Pain Suspected of Axial Spondyloarthritis in Protocolised Follow-up: Data from the Spondyloarthritis Caught Early Cohort

    Anne Boel1, Miranda van Lunteren2, Karen Fagerli3, Ulf Lindström4, Roberta Ramonda5, Marleen van de Sande6, Désirée van der Heijde7 and Floris van Gaalen8, 1Leiden University Medical Centre, Hooge Zwaluwe, Netherlands, 2Leiden University Medical Centre, Weesp, Netherlands, 3Diakonhjemmet Hospital, Oslo, Norway, 4Department of Rheumatology and inflammation research, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden., Gothenburg, Sweden, 5University of Padova, Padova, Italy, 6Amsterdam UMC, AMC/University of Amsterdam, Department of Rheumatology and Clinical Immunology, Amsterdam Infection & Immunity Institute and Amsterdam Rheumatology and Immunology Center (ARC), Amsterdam, Netherlands, 7Leiden University Medical Center, Leiden, Netherlands, 8Leiden University Medical Center (LUMC), Leiden, Netherlands

    Background/Purpose: A diagnosis of (early) axial spondyloarthritis (axSpA) is based on pattern recognition, which can be challenging and may change over time. The aim of…
  • Abstract Number: 1868 • ACR Convergence 2020

    Comparison of Quality of Life Between Chronic Back Pain Patients with and Without a Diagnosis of Axial Spondyloarthritis After 2-Year Protocolised Follow-up: Data from the Spondyloarthritis Caught Early Cohort

    Anne Boel1, Miranda van Lunteren2, Karen Fagerli3, Sofia Exarchou4, Roberta Ramonda5, Marleen van de Sande6, Désirée van der Heijde7 and Floris van Gaalen8, 1Leiden University Medical Centre, Hooge Zwaluwe, Netherlands, 2Leiden University Medical Centre, Weesp, Netherlands, 3Diakonhjemmet Hospital, Oslo, Norway, 4Rheumatology, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden, Malmo, Sweden, 5University of Padova, Padova, Italy, 6Amsterdam UMC, AMC/University of Amsterdam, Department of Rheumatology and Clinical Immunology, Amsterdam Infection & Immunity Institute and Amsterdam Rheumatology and Immunology Center (ARC), Amsterdam, Netherlands, 7Leiden University Medical Center, Leiden, Netherlands, 8Leiden University Medical Center (LUMC), Leiden, Netherlands

    Background/Purpose: The aim of this study was to compare quality of life (QoL) between chronic back pain (CBP) patients with and without a diagnosis of…
  • Abstract Number: 1869 • ACR Convergence 2020

    “Rheum to Diagnosis”: Uncovering Impediments to Accurate Diagnosis of Non-radiographic Axial Spondylarthritis (nr-axSpA)

    Sonam Kiwalkar1, Atul Deodhar1 and Richard Howard2, 1Oregon Health & Science University, Portland, OR, 2Spondylitis Association of America, Van Nuys, CA

    Background/Purpose: In the US, there is up to a 14-year delay in axSpA diagnosis, which is likely greater for nr-axSpA.1 Impediments to timely diagnosis of…
  • Abstract Number: 1870 • ACR Convergence 2020

    Development of Candidate Criteria for Axial Disease in Juvenile Spondyloarthritis: An International Collaboration

    Pamela F. Weiss1, Timothy G. Brandon2, Amita Aggarwal3, Ruben Burgos-Vargas4, Robert Colbert5, Gerd Horneff6, Rik Joos7, Ronald Laxer8, Kirsten Minden9, Angelo Ravelli10, Nicolino Ruperto11, Judith Smith12, Matthew Stoll13, Shirley Tse14, Filip Van den Bosch15 and Raymond Naden16, 1Children's Hospital of Philadelphia, Philadelphia, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, 4Department of Rheumatology, General Hospital of Mexico, Ciudad de Mexico, Mexico, 5Pediatric Clinical Trials Unit and Office of Clinical Director, NIAMS, NIH, Bethesda, MD, 6Asklepios Clinic Sankt Augustin, Sankt Augustin, Germany, 7Ziekenhuis Netwerk Antwerpen, Basel, Switzerland, 8The Hospital for Sick Children, Toronto, ON, Canada, 9Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany, 10Università degli Studi di Genova, Genoa, Italy, 11PRINTO, Istituto Giannina Gaslini, Genova, Italy, 12University of Wisconsin, Madison, WI, 13University of Alabama at Birmingham, Birmingham, AL, 14SickKids, Toronto, ON, Canada, 15Ghent University Hospital, Ghent, Belgium, 16Department of Medicine, Middlemore Hospital, Auckland, Auckland, New Zealand

    Background/Purpose: The lack of pediatric classification criteria for axial disease is a major impediment to the conduct of clinical trials for juvenile spondyloarthritis (SpA). Classification…
  • Abstract Number: 1871 • ACR Convergence 2020

    Comparison of Work Productivity Outcomes Between Chronic Back Pain Patients with and Without a Diagnosis of Axial Spondyloarthritis After 2-Year Protocolised Follow-Up: Data from the Spondyloarthritis Caught Early Cohort

    Anne Boel1, Miranda van Lunteren2, Karen Fagerli3, Roberta Ramonda4, Sofia Exarchou5, Marleen van de Sande6, Floris van Gaalen7 and Désirée van der Heijde8, 1Leiden University Medical Centre, Hooge Zwaluwe, Netherlands, 2Leiden University Medical Centre, Weesp, Netherlands, 3Diakonhjemmet Hospital, Oslo, Norway, 4University of Padova, Padova, Italy, 5Rheumatology, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden, Malmo, Sweden, 6Amsterdam UMC, AMC/University of Amsterdam, Department of Rheumatology and Clinical Immunology, Amsterdam Infection & Immunity Institute and Amsterdam Rheumatology and Immunology Center (ARC), Amsterdam, Netherlands, 7Leiden University Medical Center (LUMC), Leiden, Netherlands, 8Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: The aim of this study was to compare work-productivity and activity impairment outcomes after two-year follow-up between chronic back pain (CBP) patients with and…
  • Abstract Number: 1872 • ACR Convergence 2020

    Relative Associations of Sociodemographic, Clinical and HLA-B Alleles with Enthesitis and Peripheral Arthritis in Patients with Ankylosing Spondylitis

    Benjamin Naovarat1, Lianne Gensler2, Michael Ward3, Mark Hwang4, Matthew Brown5, Amirali Tahanan6, Mohammad Rahbar6, Mariko Ishimori7, Michael Weisman8 and John Reveille9, 1The University of Texas McGovern Medical School, Houston, TX, 2University of California San Francisco, San Francisco, CA, 3National Institutes of Health, Bethesda, MD, 4McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, 5Guy's and St Thomas, NHS Foundation Trust and King's College London NIHR Biomedical Research Centre, King's College London, London, United Kingdom, London, United Kingdom, 6McGovern Medical School at UTHealth, Houston, 7Cedars-Sinai Medical Center, Los Angeles, CA, 8Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, 9Department of Internal Medicine, University of Texas, Houston, TX

    Background/Purpose: Previous studies from Latin America have shown an association with peripheral arthritis in patients with spondyloarthritis with HLA-B*15 (as opposed to HLA-B27). We aimed…
  • Abstract Number: 1873 • ACR Convergence 2020

    The Changing Profile of Ankylosing Spondylitis in the Biologic Era

    Lauren Ridley1, Michael Weisman2, Lianne Gensler3, Michael Ward4, Mark Hwang5, Amirali Tahanan6, MinJae Lee7, Mohammad Rahbar6, Mariko Ishimori8, Matthew Brown9 and John Reveille10, 1McGovern Medical School at UTHealth, Houston, TX, 2Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, 3University of California San Francisco, San Francisco, CA, 4National Institutes of Health, Bethesda, MD, 5McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, 6McGovern Medical School at UTHealth, Houston, 7UT Southwestern, Dallas, 8Cedars-Sinai Medical Center, Los Angeles, CA, 9Guy's and St Thomas, NHS Foundation Trust and King's College London NIHR Biomedical Research Centre, King's College London, London, United Kingdom, London, United Kingdom, 10Department of Internal Medicine, University of Texas, Houston, TX

    Background/Purpose: To compare disease characteristics, comorbidities, and medication utilization of 573 patients with ankylosing spondylitis (AS) with short (< 20 years) disease duration (from symptom…
  • Abstract Number: 1874 • ACR Convergence 2020

    Differences Between Men and Women in the Patient Pathways to Diagnosis of Ankylosing Spondylitis

    Mark Hwang1, Martin Rozycki2, Theresa Arndt2, Esther Yi3 and Michael Weisman4, 1McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, 2HVH Precision Analytics, LLC, Wayne, PA, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, 4Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA

    Background/Purpose: Healthcare claims databases can be used to identify patients with ankylosing spondylitis (AS) prior to diagnosis. This study explores differences in pathways to AS…
  • Abstract Number: 1875 • ACR Convergence 2020

    Heterogeneity Amongst Men and Women with Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

    Zhixiu Li1, Muhammad Khan2, Mohammad Khan3, Peter Villiger4, Heinz Baumberger5, Hermine Zandwijk6, Sjef van der Linden7 and Matthew Brown8, 1Queensland University of Technology (QUT), Translational Genomics Group, School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Qld, Australia, Brisbane, Queensland, Australia, 2Case Western Reserve University, Cleveland OH, Westlake, OH, 3Kent State University, Kent, OH, 4Department of Rheumatology, Immunology and Allergology, University of Bern, Inselspital, Switzerland, Bern, Switzerland, 5Retired, Flims, Tajikistan, 6Retired, Mortroux, Belgium, 7Department of Rheumatology, Immunology and Allergology, University of Bern, Inselspital, Bern, Switzerland, Mortroux, Belgium, 8Guy's and St Thomas, NHS Foundation Trust and King's College London NIHR Biomedical Research Centre, King's College London, London, United Kingdom, London, United Kingdom

    Background/Purpose: Axial spondyloarthritis (axSpA) includes both ankylosing spondylitis (AS) and non-radiographic axial disease (nr-axSpA). Our purpose was to investigate genetic heterogeneity of clinically diagnosed axSpA.Methods:…
  • Abstract Number: 1876 • ACR Convergence 2020

    The Role of HLA B27 in Axial Spondyloarthritis: Prevalence and Performance as a Marker in an Argentinian Cohort

    Rodrigo Garcia Salinas1, Santiago Ruta1, Einer Sanchez Prado1, Jessica Torres Chichande1, Alvaro Ruta1, Facundo Salvatori1 and Sebastian Magri1, 1Hospital Italiano La Plata, La Plata, Argentina

    Background/Purpose: HLA B27 prevalence in Latin America are heterogeneous and timeless, we propose to estimate the prevalence of HLA B27 in an Argentinian cohort of…
  • Abstract Number: 1877 • ACR Convergence 2020

    Diagnosis of Axial Spondyloarthritis: A Primary Unmet Educational Need for Rheumatologists Is Interpretation of MRI

    Walter Maksymowych1, Liron Caplan2, Atul Deodhar3, Soha Dolatabadi4, Mark Hwang5, Adam Carlson6, Kelly Steed7, Amanda Carapellucci8, Joel Paschke8 and Lianne Gensler9, 1University of Alberta, Edmonton, AB, Canada, 2Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO, 3Oregon Health & Science University, Portland, OR, 4Soha Dolatabadi, MD, Los Angeles, CA, 5McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, 6University of Virginia, Charlottesville, VA, 7James J. Peters VA Medical Center, Bronx, NY, 8CARE Arthritis, Edmonton, AB, Canada, 9University of California San Francisco, San Francisco, CA

    Background/Purpose: Diagnosis of axial spondyloarthritis (axSpA) is challenging because of absent physical findings in early disease and the limited diagnostic performance of laboratory markers. Considerable…
  • Abstract Number: 1878 • ACR Convergence 2020

    Consensus Definitions for MRI Lesions in the Spine of Patients with Axial Spondyloarthritis: First Analysis from the Assessments in SpondyloArthritis International Society Classification Cohort

    Walter Maksymowych1, Iris Eshed2, Pedro M Machado3, Susanne J Pedersen4, Ulrich Weber5, Manouk de Hooge6, Joachim Sieper7, Stephanie Wichuk1, Denis Poddubnyy8, Martin Rudwaleit9, Désirée van der Heijde10, Robert Landewé11, Robert G Lambert12, Mikkel Østergaard13 and Xenofon Baraliakos14, 1University of Alberta, Edmonton, AB, Canada, 2Sheba Medical Center, Tel-Aviv, Israel, 3University College London, London, United Kingdom, 4Rigshospitalet University, Copenhagen, Denmark, 5University of South Denmark, Odense, Denmark, 6Ghent University Hospital, Ghent, Belgium, 7Charité Universitätsmedizin Berlin, Berlin, Germany, 8Charité – Universitätsmedizin Berlin, Berlin, Germany, 9Department of Internal Medicine and Rheumatology, Klinikum Bielefeld, Germany, 10Leiden University Medical Center, Leiden, Netherlands, 11Amsterdam University Medical Center & Zuyderland Hospital, Amsterdam, Netherlands, 12University of Alberta and CARE Arthritis, Edmonton, AB, Canada, 13Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, 14Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany

    Background/Purpose: A broad spectrum of MRI lesions has been described in the spine of patients with axial spondyloarthritis (axSpA) and a recent consensus from the…
  • Abstract Number: 1879 • ACR Convergence 2020

    Development of a Deep Learning Algorithm to Predict Positive MRI of the Sacroiliac Joints According to the ASAS Definition in Patients with Recent Axial Spondyloarthritis

    Théodore Aouad1, Clementina Lopez-Medina2, Anna Molto2, Antoine Feydy3, Charlotte Martin-Peltier3, Hugues Talbot4 and Maxime Dougados5, 1Université Paris-Saclay, CentraleSupelec, Inria, Gif-Sur-Yvette, France, 2Rheumatology Department, Cochin Hospital, Paris, Paris, France, 3Radiology Department, Cochin Hospital, Paris, France, 4CVN, CentraleSupelec, Paris, France, 5Department of Rheumatology, Hopital Cochin, Université de Paris, Paris, France

    Background/Purpose: The magnetic resonance imaging (MRI) of the sacroiliac joints (MRI-SIJ) represents an essential tool in the evaluation of patients with spondyloarthritis (SpA). However, despite…
  • « Previous Page
  • 1
  • …
  • 777
  • 778
  • 779
  • 780
  • 781
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology